today announced that Igor Matushansky, MD, PhD, has joined the company as Chief Medical Officer. In this role, he will direct Immuneering’s clinical activities, providing medical and operational ...

(RTTNews) - Immuneering Corp. (IMRX), a clinical-stage oncology company, Thursday announced that Igor Matushansky has joined the firm as Chief Medical Officer. The appointment comes as Immuneering ...

In 1945, Igor Gouzenko and his family received new identities from the Canadian government after the young Russian Embassy cipher clerk announced he had proof of a widespread spy ring in Canada.

March 20, 2025 (GLOBE NEWSWIRE) -- Immuneering (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, ...

today announced that Igor Matushansky, MD, PhD, has joined the company as Chief Medical Officer. In this role, he will direct Immuneering's clinical activities, providing medical and operational ...